BIOHM Gut Test

The displayed $194.99 price, free-shipping threshold, FSA/HSA statement, refund window, sample-submission deadline, reprocessing terms, and post-submission refund limit are public and decision-useful. The total delivered cost, taxes, promotion conditions, and current pricing for the optional live-consult route are not fully resolved.

For the declared bacterial and fungal composition question, BIOHM publishes bacterial and fungal phyla, named species or groups, Candida measurements, and comparison reporting. BIOHM's methodology article says that only dozens of organisms associated with health and wellness are shown and transient organisms are excluded, so this is useful for the stated narrow question but not a complete gut or gastrointestinal workup.

The report structure is understandable on its face: a 1 to 10 score, comparisons with normal levels, strain-by-strain higher or lower results, and written recommendations. The provider does not publish the score algorithm, reference-population construction, uncertainty treatment, or a complete follow-up framework, and its Terms do not warrant accurate or reliable results.

BIOHM documents a bacterial and fungal DNA workflow with quality control, extraction, polymerase chain reaction, library preparation, and sequencing, and official provider pages identify Case Western Reserve University School of Medicine as the analysis location. The public evidence does not document the assay platform, target regions, product-specific precision, accuracy, validation, or laboratory credential identifiers.

The at-home fecal swab, prepaid USPS return, sample registration, online portal, US-only shipping, standard delivery estimate, and no-expedited-return limitation are documented. The unresolved turnaround conflict, unknown state-level restrictions, and requirement for an internet-connected device and valid email create bounded workflow friction.

Current Terms provide unusually specific disclosures about de-identified and identifiable sample retention, future reanalysis, research and proprietary use, redistribution or sale of de-identified samples, irreversible processing, and individual disclosure limits. The terms do not provide a clear deletion procedure or timeline, and they conflict with an older BIOHM Q&A that says customer data is not collected, reused, aggregated, analyzed, or sold, so privacy controls require human resolution.

The product is directly relevant to a narrowly declared personal microbiome and wellness education question because it reports bacterial and fungal communities, comparative levels, a diversity score, and wellness recommendations. The provider also states that the service is not diagnostic and directs users to health professionals, while the evidence does not establish disease diagnosis, exclusion, or treatment value.

BIOHM publishes the product route, price, specimen and return workflow, report sections, geographic access, refund terms, and extensive sample and data-use terms. Transparency remains limited by missing platform, target-region, validation, credential, reference-cohort, and product-specific deletion details, plus the unresolved turnaround and privacy statements.